The effects of ketorolac tromethamine and baicalein on the levels of inflammatory factors in human synoviocytes

Archives of Pharmacal Research

Volumn 31, Issue 11, 2008, Pages 1517-1523

  Yang, Jae Heon ^a   Yun, Mi Young ^b   Lee, Nam Hee ^a   Kim, Dae Keun ^a   Kim, Young Il ^c   Noh, Young Hee ^c   Kim, Tae Youl ^d   Yoon, Se Won ^e   Shin, Sang Chul ^f  

^a Woosuk University   (South Korea)

^b Daejeon University   (South Korea)

^c Konyang University   (South Korea)

^d Dongshin University   (South Korea)

^e Sunlin Hospital   (South Korea)

^f Chonnam National University   (South Korea)

Author keywords

Baicalein; Human fibroblast like synoviocytes; IL 1 mRNA; IL 6; Ketorolac tromethamine; TNF

Indexed keywords

AUTACOID; BAICALEIN; FLAVANONE DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KETOROLAC TROMETAMOL; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; SYNOVIAL FLUID;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; FLAVANONES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; KETOROLAC TROMETHAMINE; PROSTAGLANDIN ANTAGONISTS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, FLUORESCENCE; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56749154860     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-2138-6     Document Type: Article

References (22)

1. J. B. Allen C. L. Manthey A. R. Hand 1990 Rapid onset of synovial inflammation and hyperplasia induced by transforming growth factor beta J. Exp. Med. 171 231 247
2. M. T. Buckley R. N. Brogden 1990 Ketorolac: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential Drugs. 39 86 109
3. B. Dasgupta M. Corkill B. Kirkham T. Gibson G. Panayi 1992 Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis J. Rheumatol. 19 22 25
4. J. A. Forbes G. A. Butterworth W. H. Burchfield W. T. Beaver 1990 Evaluation ketorolac, aspirin and an acetaminophen-codeine combination in post operative oral surgery pain Pharmacother. 10 suppl. 77 93
5. L. Genestier R. Paillot S. Fournel C. Ferraro P. Miossec J. P. Revillard 1998 Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells J Clin Invest. 102 322 328
6. V. Granados-Soto F. J. Flores-Murrieta 1995 Castaneda-Hernandez, G., and Hong, E., Evidence against the participation of μ-and κ-opioid receptors in the analgesic activity of Ketorolac in rats J. Pharm. Pharmacol. 47 514 517
7. S. Y. Hwang J. Y. Kim K. W. Kim M. K. Park Y. Moon W. U. Kim H. Y. Kim 2004 IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB-and PI3-kinase/Akt-dependent pathways Arthritis Res. Ther. 6 120 128
8. A. Jungel J. H. Distler M. Kurowska-Stolarska C. A. Seemayer R. Seibl A. Forster B. A. Michel R. E. Gay M. Emmrich S. Gay O. Distler 2004 Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis Arthritis Rheum. 50 1468 1476
9. Y. Konto G. Kollias 2000 Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line Arthritis Res. 2 342 343
10. Y. T. Konttinen M. Ainola H. Valleala J. Ma H. Ida J. Mandelin 1999 Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis Ann Rheum Dis. 58 691 697
11. D. Krause B. Schleusser G. Herborn R. Rau 2000 Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis Arthritis Rheum. 43 14 21
12. M. J. Lee M. Kim Y. S. Lee C. G. Shin 2003 Baicalein and baicalin as inhibitors of HIV-1 intergrase Yakhak Hoeji 47 46 51
13. J. Martel-Pelletier D. J. Welsch J. P. Pelletier 2001 Metalloproteases and inhibitors in arthritic diseases Best Pract. Res. Clini. Rheumatol. 15 805 829
14. D. W. McCarey I. B. McInnes R. Madhok R. Hampson O. Scherbakov I. Ford 2004 Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial Lancet 363 2015 2021
15. M. Miranda-Carus E. A. Balsa M. Benito-Miguel C. Perez de Ayala E. Martin-Mola 2004 IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate J. Immunol. 173 1463 1476
16. J. C. Morel C. C. Park K. Zhu 2002 Signal transduction pathways involved in rheumatoid synovial fibroblast inter-leukin-18-induced vascular cell adhesion molecule-1 expression J. Biol. Chem. 38 34679 34691
17. N. Nishimoto K. Yoshizaki N. Miyasaka K. Yamamoto S. Kawai T. Takeuchi 2004 Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody Arthritis Rheum. 50 1761 1769
18. D. A. O'Hara R. J. Grangen M. Kinzer D. Pemberton 1987 Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain Clin. Pharmacol. Ther. 41 556 561
19. T. Pap U. Muller-Ladner R. E. Gay 2000 Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis Arthritis Res. 2 361 367
20. D. Wendling E. Racadot J. Wijdenes 1993 Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody J. Rheumatol. 20 259 262
21. J. H. Yang N. H. Lee 2005 Skin permeation and crosslinking with biological tissue of the hydrolyzed products of gardeniae fructus extracts J. Kor. Pharm, Sci. 35 7 16
22. J. Yee C. Allison J. Koshiver C. R. Brown 1986 Analgesia from intramuscular ketorolac tromethamine compared to morphine sulfate in severe pain following major surgery Pharmacother. 6 253 261